Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Interest Expenses (2016 - 2023)

HealthLynked (HLYK) has disclosed Interest Expenses for 7 consecutive years, with -$110000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Interest Expenses fell 177319.35% to -$110000.0 in Q4 2022 year-over-year; TTM through Sep 2023 was -$110000.0, a 192.09% decrease, with the full-year FY2023 number at $21331.0, changed N/A from a year prior.
  • Interest Expenses was -$110000.0 for Q4 2022 at HealthLynked, down from $110000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $227075.0 in Q4 2019 to a low of -$110000.0 in Q4 2022.
  • A 5-year average of $34641.1 and a median of $41724.0 in 2018 define the central range for Interest Expenses.
  • Biggest YoY gain for Interest Expenses was 2571.2% in 2022; the steepest drop was 177319.35% in 2022.
  • HealthLynked's Interest Expenses stood at $43101.0 in 2018, then skyrocketed by 426.84% to $227075.0 in 2019, then tumbled by 75.06% to $56625.0 in 2020, then tumbled by 100.11% to -$62.0 in 2021, then crashed by 177319.35% to -$110000.0 in 2022.
  • Per Business Quant, the three most recent readings for HLYK's Interest Expenses are -$110000.0 (Q4 2022), $110000.0 (Q3 2022), and $4488.0 (Q2 2022).